373 / 1631
CR/CRu
No CR/CRu
Combined Modality vs 4-6 x ABVD alone
Status after 2xABVD (HD10 eligible pts; PFS)
Hay et al Ann Oncol. 2013 Dec;24(12):3065-9
|
|
373 / 1631
CR/CRu
No CR/CRu
Combined Modality vs 4-6 x ABVD alone
Status after 2xABVD (HD10 eligible pts; PFS)
Hay et al Ann Oncol. 2013 Dec;24(12):3065-9